J&J sees AI halving the time to generate drug development leads
Johnson & Johnson is using the new technology to screen the 'potential universe' for promising chemical compounds or biologics, CIO Jim Swanson says
ORIGINAL SOURCE →via Rappler Philippines
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · tech
- [TECH] Launch: Ariane 64 | Amazon Leo (LE-02)
- [TECH] Will break your legs: Delhi cloud kitchen owner vs cops over bribe claims
- [TECH] Denso to keep up chip partnerships even after halting Rohm bid
- [TECH] OpenAI and the New Cognitive Architecture of Software Repositories
- [TECH] ‘AI deflation’ comes to India’s tech services giants and puts downward pressure on revenue
- [TECH] Claude MCP Explained: Building Enterprise AI Integrations That Actually Scale